https://pubmed.ncbi.nlm.nih.gov/41844941/
Targeting NK cell CLEC12B enhances cancer immunotherapy
Natural killer (NK) cells are innate immune effectors, but their cytotoxic potential can be compromised within the immunosuppressive tumor microenvironment....
nk celltargetingenhancescancerimmunotherapy